Your browser doesn't support javascript.
loading
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA.
Matsubara, Nobuaki; de Bono, Johann; Olmos, David; Procopio, Giuseppe; Kawakami, Satoru; Ürün, Yüksel; van Alphen, Robbert; Flechon, Aude; Carducci, Michael A; Choi, Young Deuk; Hotte, Sebastien J; Korbenfeld, Ernesto; Kramer, Gero; Agarwal, Neeraj; Chi, Kim N; Dearden, Simon; Gresty, Christopher; Kang, Jinyu; Poehlein, Christian; Harrington, Elizabeth A; Hussain, Maha.
Affiliation
  • Matsubara N; National Cancer Center Hospital East, Chiba, Japan.
  • de Bono J; The Institute of Cancer Research and Royal Marsden, London, United Kingdom.
  • Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Procopio G; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
  • Kawakami S; Medical Oncology Dept, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ürün Y; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • van Alphen R; Department of Medical Oncology, Ankara University, Ankara, Turkey.
  • Flechon A; Department of Oncology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.
  • Carducci MA; Cancérologie Médicale, Centre Léon-Bérard, Lyon Cedex, France.
  • Choi YD; Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland.
  • Hotte SJ; Department of Urology, Yonsei University Severance Hospital, Seoul, Republic of South Korea.
  • Korbenfeld E; Juravinski Cancer Centre, Hamilton, Ontario, Canada.
  • Kramer G; Hospital Britanico de Buenos Aires, Buenos Aires, Argentina.
  • Agarwal N; AKH Wien, Vienna, Austria.
  • Chi KN; Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, Utah.
  • Dearden S; University of British Columbia, Vancouver, Canada.
  • Gresty C; AstraZeneca, Cambridge, United Kingdom.
  • Kang J; AstraZeneca, Cambridge, United Kingdom.
  • Poehlein C; AstraZeneca, Gaithersburg, Maryland.
  • Harrington EA; Merck & Co., Inc., Rahway, New Jersey.
  • Hussain M; AstraZeneca, Cambridge, United Kingdom.
Clin Cancer Res ; 29(1): 92-99, 2023 01 04.
Article in En | MEDLINE | ID: mdl-36318705
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Circulating Tumor DNA Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Circulating Tumor DNA Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article